CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
Early Surgical Hematoma Evacuationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02880878
NCT02880878N/ACompleted
CompareCT.gov

ENRICH: A Multi-center, Randomized, Clinical Trial Comparing Standard Medical Management to Early Surgical Hematoma Evacuation Using Minimally Invasive Parafascicular Surgery (MIPS) in the Treatment of Intracerebral Hemorrhage (ICH).

Nico Corporation·interventional·Posted Aug 26, 2016·Updated May 10, 2023

In Brief

A clinical study evaluating Early Surgical Hematoma Evacuation for Intracerebral Hemorrhage and 2 related conditions. Completed, enrolled 300 participants across 36 sites.

Detailed Summary

This is a multicenter, randomized, adaptive clinical trial comparing standard medical management to early (\<24 hours) surgical hematoma evacuation using minimally invasive parafascicular surgery (MIPS) in the treatment of acute spontaneous supratentorial intracerebral hemorrhage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracerebral Hemorrhage, Cerebral Hemorrhage, Intracerebral Haemorrhage
CountriesUnited States
CollaboratorsEmory University

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 26, 2016
Enrollment StartDec 1, 2016
Primary CompletionAug 1, 2022
Study CompletionFeb 1, 2023
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 9.8 years ago

Interventions

Early Surgical Hematoma Evacuationprocedure

Early Minimally Invasive Parafascicular Surgery (MIPS)